REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 113 filers reported holding REVANCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,062,982 | -58.6% | 92,675 | -8.7% | 0.00% | -50.0% |
| Q2 2023 | $2,569,826 | -22.0% | 101,534 | -0.8% | 0.00% | -20.0% |
| Q1 2023 | $3,295,598 | +73.8% | 102,316 | -0.4% | 0.01% | +66.7% |
| Q4 2022 | $1,896,728 | -28.2% | 102,748 | +5.0% | 0.00% | -25.0% |
| Q3 2022 | $2,642,000 | +116.7% | 97,856 | +10.9% | 0.00% | +100.0% |
| Q2 2022 | $1,219,000 | -29.4% | 88,214 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,727,000 | +10.2% | 88,547 | -7.8% | 0.00% | 0.0% |
| Q4 2021 | $1,567,000 | -39.9% | 96,025 | +2.7% | 0.00% | -33.3% |
| Q3 2021 | $2,606,000 | -9.2% | 93,535 | -3.4% | 0.00% | -25.0% |
| Q2 2021 | $2,869,000 | +8.2% | 96,799 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $2,652,000 | -1.8% | 94,893 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $2,700,000 | +12.8% | 95,261 | +0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,394,000 | +14.5% | 95,235 | +11.2% | 0.00% | 0.0% |
| Q2 2020 | $2,091,000 | +80.1% | 85,625 | +9.1% | 0.00% | +33.3% |
| Q1 2020 | $1,161,000 | +4.2% | 78,450 | +14.3% | 0.00% | +50.0% |
| Q4 2019 | $1,114,000 | +24.9% | 68,618 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $892,000 | +1.5% | 68,618 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $879,000 | -5.9% | 67,799 | +14.4% | 0.00% | 0.0% |
| Q1 2019 | $934,000 | -9.7% | 59,257 | +15.4% | 0.00% | 0.0% |
| Q4 2018 | $1,034,000 | -17.1% | 51,364 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $1,248,000 | -9.5% | 50,206 | -0.0% | 0.00% | -33.3% |
| Q2 2018 | $1,379,000 | +9.3% | 50,223 | +22.5% | 0.00% | 0.0% |
| Q1 2018 | $1,262,000 | -2.3% | 40,990 | +13.4% | 0.00% | 0.0% |
| Q4 2017 | $1,292,000 | +28.4% | 36,132 | -1.1% | 0.00% | +50.0% |
| Q3 2017 | $1,006,000 | -4.2% | 36,522 | -8.2% | 0.00% | 0.0% |
| Q2 2017 | $1,050,000 | +25.3% | 39,770 | -1.2% | 0.00% | 0.0% |
| Q1 2017 | $838,000 | -3.8% | 40,270 | -4.3% | 0.00% | 0.0% |
| Q4 2016 | $871,000 | +24.3% | 42,070 | -2.8% | 0.00% | +100.0% |
| Q3 2016 | $701,000 | +20.2% | 43,270 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $583,000 | -13.9% | 42,870 | +10.5% | 0.00% | 0.0% |
| Q1 2016 | $677,000 | -41.6% | 38,794 | +14.2% | 0.00% | -66.7% |
| Q4 2015 | $1,160,000 | +37.0% | 33,966 | +19.3% | 0.00% | +50.0% |
| Q3 2015 | $847,000 | -7.3% | 28,474 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $914,000 | +177.0% | 28,574 | +79.3% | 0.00% | +100.0% |
| Q1 2015 | $330,000 | +22.2% | 15,940 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $270,000 | -12.1% | 15,940 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $307,000 | -28.3% | 15,872 | +26.0% | 0.00% | 0.0% |
| Q2 2014 | $428,000 | +7.8% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $397,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |